formula for preterm infants
PreclinicalBiologic
formula for preterm infants is one of 12 biologic programs targeting Amenorrhea. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
11
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
19 competitors in Amenorrhea
#DrugCompanyPhaseTrials
1Glucophage
EMD SeronoApproved
Zometa
PfizerPhase 3
Prometrium
FerringPhase 3
Romosozumab
AmgenPhase 3
Myalept
Chiesi Farmaceutici S.p.A.Phase 2
Kisspeptin
MMassachusetts General Hospital
Phase 2
Mibavademab
RegeneronPhase 2
Cytotec
PfizerPreclinical
Kisspeptin 112-121
SStephanie B. Seminara, MD
Phase 2
Oral Contraceptive Pills
SSheba Medical Center
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Amenorrhea1 trial
Impact of Oropharyngeal Administration of Colostrum in the First 48 Hours of Life Term Premature Newborn ≤ 32 Weeks of Amenorrhea
Completed·—·N/A·NCT02650167·140 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for formula for preterm infants. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details